ADAM C DERBYSHIRE Insider Trading $SLXP SALIX PHARMACEUTICALS LTD
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ADAM C DERBYSHIRE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ADAM C DERBYSHIRE. ADAM C DERBYSHIRE is EVP Finance/CFO in SALIX PHARMACEUTICALS LTD ($SLXP) and Sr. VP Finance/CFO in SALIX PHARMACEUTICALS LTD ($SLXP).
ADAM C DERBYSHIRE in SALIX PHARMACEUTICALS LTD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ADAM C DERBYSHIRE: EVP Finance/CFO, Sr. VP Finance/CFO
Holdings: 133,990 shares
Latest Transaction: Jul 06 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ADAM C DERBYSHIRE in SALIX PHARMACEUTICALS LTD
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.52 | 100 | 952 | 83,589 | 83.7 K to 83.6 K (-0.12 %) |
| Jun 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.53 | 200 | 1,906 | 83,689 | 83.9 K to 83.7 K (-0.24 %) |
| Jun 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.54 | 100 | 954 | 83,889 | 84 K to 83.9 K (-0.12 %) |
| Jun 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.55 | 300 | 2,865 | 83,989 | 84.3 K to 84 K (-0.36 %) |
| Jun 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.59 | 100 | 959 | 84,289 | 84.4 K to 84.3 K (-0.12 %) |
| Jun 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |
| Jun 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.11 | 54 | 492 | 83,389 | 83.4 K to 83.4 K (-0.06 %) |
| Jun 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.12 | 46 | 420 | 83,443 | 83.5 K to 83.4 K (-0.06 %) |
| Jun 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.27 | 100 | 927 | 83,489 | 83.6 K to 83.5 K (-0.12 %) |
| Jun 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.28 | 200 | 1,856 | 83,589 | 83.8 K to 83.6 K (-0.24 %) |
| Jun 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.31 | 200 | 1,862 | 83,789 | 84 K to 83.8 K (-0.24 %) |
| Jun 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.33 | 356 | 3,321 | 83,989 | 84.3 K to 84 K (-0.42 %) |
| Jun 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.34 | 44 | 411 | 84,345 | 84.4 K to 84.3 K (-0.05 %) |
| Jun 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 139,000 | |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 140,000 | |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 141,000 | |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 8.83 | 100 | 883 | 83,389 | 83.5 K to 83.4 K (-0.12 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 8.85 | 100 | 885 | 83,489 | 83.6 K to 83.5 K (-0.12 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 8.87 | 100 | 887 | 83,589 | 83.7 K to 83.6 K (-0.12 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 8.90 | 100 | 890 | 83,689 | 83.8 K to 83.7 K (-0.12 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 8.93 | 100 | 893 | 83,789 | 83.9 K to 83.8 K (-0.12 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.00 | 300 | 2,700 | 83,889 | 84.2 K to 83.9 K (-0.36 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.03 | 200 | 1,806 | 84,189 | 84.4 K to 84.2 K (-0.24 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | M | 1.13 | 1,000 | 1,133 | 84,389 | 85.4 K to 84.4 K (-1.17 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 8.93 | 100 | 893 | 83,389 | 83.5 K to 83.4 K (-0.12 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 8.98 | 100 | 898 | 83,489 | 83.6 K to 83.5 K (-0.12 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.00 | 100 | 900 | 83,589 | 83.7 K to 83.6 K (-0.12 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.01 | 700 | 6,307 | 83,689 | 84.4 K to 83.7 K (-0.83 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 8.92 | 100 | 892 | 83,389 | 83.5 K to 83.4 K (-0.12 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 8.94 | 300 | 2,682 | 83,489 | 83.8 K to 83.5 K (-0.36 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 8.95 | 400 | 3,580 | 83,789 | 84.2 K to 83.8 K (-0.48 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.00 | 200 | 1,800 | 84,189 | 84.4 K to 84.2 K (-0.24 %) |
| May 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.52 | 200 | 1,904 | 80,389 | 80.6 K to 80.4 K (-0.25 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.62 | 100 | 962 | 80,589 | 80.7 K to 80.6 K (-0.12 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.69 | 400 | 3,876 | 80,689 | 81.1 K to 80.7 K (-0.49 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.70 | 100 | 970 | 81,089 | 81.2 K to 81.1 K (-0.12 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.73 | 100 | 973 | 81,189 | 81.3 K to 81.2 K (-0.12 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.75 | 100 | 975 | 81,289 | 81.4 K to 81.3 K (-0.12 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.63 | 200 | 1,926 | 81,389 | 81.6 K to 81.4 K (-0.25 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.66 | 700 | 6,762 | 81,589 | 82.3 K to 81.6 K (-0.85 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.72 | 100 | 972 | 82,289 | 82.4 K to 82.3 K (-0.12 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.76 | 100 | 976 | 82,389 | 82.5 K to 82.4 K (-0.12 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.77 | 100 | 977 | 82,489 | 82.6 K to 82.5 K (-0.12 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.78 | 100 | 978 | 82,589 | 82.7 K to 82.6 K (-0.12 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.79 | 100 | 979 | 82,689 | 82.8 K to 82.7 K (-0.12 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.80 | 100 | 980 | 82,789 | 82.9 K to 82.8 K (-0.12 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.81 | 100 | 981 | 82,889 | 83 K to 82.9 K (-0.12 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.82 | 100 | 982 | 82,989 | 83.1 K to 83 K (-0.12 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.83 | 200 | 1,966 | 83,089 | 83.3 K to 83.1 K (-0.24 %) |
| May 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.86 | 100 | 986 | 83,289 | 83.4 K to 83.3 K (-0.12 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 142,000 | |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 143,000 | |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 8.78 | 100 | 878 | 83,389 | 83.5 K to 83.4 K (-0.12 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 8.79 | 300 | 2,637 | 83,489 | 83.8 K to 83.5 K (-0.36 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 8.82 | 100 | 882 | 83,789 | 83.9 K to 83.8 K (-0.12 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 8.83 | 100 | 883 | 83,889 | 84 K to 83.9 K (-0.12 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 8.85 | 200 | 1,770 | 83,989 | 84.2 K to 84 K (-0.24 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 8.86 | 100 | 886 | 84,189 | 84.3 K to 84.2 K (-0.12 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 8.87 | 27 | 239 | 84,289 | 84.3 K to 84.3 K (-0.03 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 8.91 | 73 | 650 | 84,316 | 84.4 K to 84.3 K (-0.09 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.28 | 100 | 928 | 83,389 | 83.5 K to 83.4 K (-0.12 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.31 | 300 | 2,793 | 83,489 | 83.8 K to 83.5 K (-0.36 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.32 | 100 | 932 | 83,789 | 83.9 K to 83.8 K (-0.12 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.33 | 314 | 2,930 | 83,889 | 84.2 K to 83.9 K (-0.37 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.34 | 86 | 803 | 84,203 | 84.3 K to 84.2 K (-0.10 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.37 | 100 | 937 | 84,289 | 84.4 K to 84.3 K (-0.12 %) |
| May 26 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 147,000 | |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 148,000 | |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 149,000 | |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.53 | 100 | 953 | 83,389 | 83.5 K to 83.4 K (-0.12 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.55 | 100 | 955 | 83,489 | 83.6 K to 83.5 K (-0.12 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.58 | 100 | 958 | 83,589 | 83.7 K to 83.6 K (-0.12 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.60 | 100 | 960 | 83,689 | 83.8 K to 83.7 K (-0.12 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.61 | 100 | 961 | 83,789 | 83.9 K to 83.8 K (-0.12 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.62 | 100 | 962 | 83,889 | 84 K to 83.9 K (-0.12 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.64 | 200 | 1,928 | 83,989 | 84.2 K to 84 K (-0.24 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.80 | 200 | 1,960 | 84,189 | 84.4 K to 84.2 K (-0.24 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.37 | 197 | 1,846 | 83,389 | 83.6 K to 83.4 K (-0.24 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.38 | 300 | 2,814 | 83,586 | 83.9 K to 83.6 K (-0.36 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.39 | 100 | 939 | 83,886 | 84 K to 83.9 K (-0.12 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.42 | 100 | 942 | 83,986 | 84.1 K to 84 K (-0.12 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.44 | 100 | 944 | 84,086 | 84.2 K to 84.1 K (-0.12 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.45 | 203 | 1,918 | 84,186 | 84.4 K to 84.2 K (-0.24 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.73 | 200 | 1,946 | 83,389 | 83.6 K to 83.4 K (-0.24 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 9.74 | 800 | 7,792 | 83,589 | 84.4 K to 83.6 K (-0.95 %) |
| May 18 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |
| Jul 03 2008 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Grant | A | 0.00 | 27,000 | 0 | 83,389 | 56.4 K to 83.4 K (+47.88 %) |
| Jul 03 2008 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Payment of Exercise | F | 7.03 | 3,106 | 21,835 | 56,389 | 59.5 K to 56.4 K (-5.22 %) |
| May 14 2008 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Buy | P | 7.12 | 1,000 | 7,115 | 59,495 | 58.5 K to 59.5 K (+1.71 %) |
| Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 12.29 | 790 | 9,709 | 58,495 | 59.3 K to 58.5 K (-1.33 %) |
| Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 12.30 | 100 | 1,230 | 59,285 | 59.4 K to 59.3 K (-0.17 %) |
| Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 12.31 | 200 | 2,462 | 59,385 | 59.6 K to 59.4 K (-0.34 %) |
| Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 12.32 | 300 | 3,696 | 59,585 | 59.9 K to 59.6 K (-0.50 %) |
| Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 12.33 | 400 | 4,932 | 59,885 | 60.3 K to 59.9 K (-0.66 %) |
| Jul 03 2007 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Grant | A | 0.00 | 19,385 | 0 | 60,285 | 40.9 K to 60.3 K (+47.40 %) |
| Mar 08 2007 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Grant | A | 12.87 | 1,000 | 12,870 | 40,900 | 39.9 K to 40.9 K (+2.51 %) |
| Jul 17 2006 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Grant | A | 0.00 | 18,900 | 0 | 39,900 | 21 K to 39.9 K (+90.00 %) |